Yılmaz, R.Adaş, G.Çukurova, Z.Yaşar, Kart K.Işıksaçan, N.Öztel, O. N.Karaöz, Erdal2021-01-062021-01-062020Yilmaz, R., Adas, G., Cukurova, Z., Isiksacan, N., Oztel, O. N., & Karaoz, E. (2020). Mesenchymal stem cells treatment in COVID-19 patient with multi-organ involvement. Bratislavske lekarske listy, 121(12), 847-852.0006-92481336-0345https://doi.org/10.4149/BLL_2020_139https://hdl.handle.net/20.500.12713/1304The aim of this study is to evaluate the therapeutic effect of mesenchymal stem cells (MSCs) in a severe case of brain and multiple organ involvement in a patient with COVID-19. Here, a 51-year-old male patient with multi-organ involvement due to COVID-19 infection and developing cardiac arrest is presented. MSCs were transplanted to the patient four times systematically and once intrathecally. As a result, the application of MSCs has been found to have a healing effect on organs in this patient with severe COVID-19 infection. In addition, transplantation of MSCs both systematically and intrathecally is considered to be effective in the treatment of the central nervous system (Tab. 2, Fig. 2, Ref. 24). Text in PDF www.elis.skeninfo:eu-repo/semantics/openAccessMesenchymal Stem CellCOVID-19Organ InvolvementMesenchymal stem cells treatment in COVID-19 patient with multi-organ involvementArticle121284785233300352WOS:0005996400000032-s2.0-85097916202Q310.4149/BLL_2020_139Q3